LinqMed Inc.
PrivateLast Round
Series B
Extension
May 12, 2025
Total Funding Raised
$39.55M
Company Overview
LinqMed Inc. is a radiopharmaceutical company developing a drug discovery platform and innovative 'visible' anti-cancer treatments using the copper radioisotope 64Cu.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine, Medical Imaging
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LinqMed Inc. Comps
Public and private peers based on sector, stage, and business model.
LinqMed Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | May 12, 2025 | ||||
| Series B Extension | Apr 9, 2025 | ||||
| Series B | Jan 10, 2025 | ||||
| Series A | Dec 22, 2023 | ||||
| Grant | Dec 22, 2023 |
LinqMed Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sumitomo Mitsui Trust Bank | Series B Extension |
| Keio Innovation Initiative | Series B Extension |
| Mizuho Capital | Series A |
| New Energy and Industrial Technology Development Organization | Grant |
| Mitsubishi UFJ Life Science Funds | Series B Extension |
| Chibagin Capital | Series B Extension |
| Nissay Capital | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2025
$2M round with Nissay Capital participating.
- Apr 9, 2025
$14.47M round with Sumitomo Mitsui Trust Bank and Chibagin Capital.
LinqMed Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
